Evidence map›Paper›PMID 41964054›Full record

ArticleBMC research notes2026

Protocol deviation outlier estimation combined with generative AI.

Ioannis I Spyroglou, Magdaléna Řeháková, Radim Klapka, Anna Kacprzycka, Maria Consuelo Luguera Fernandez, Ronojit Adyanthaya, Kyle Young, Jolie Weintraub

Abstract read
In one paragraph

Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ioannis I SpyroglouMerck & Co., Inc., Rahway, NJ, 07065, USA. ioannis.spyroglou@msd.com.
Magdaléna ŘehákováMerck & Co., Inc., Rahway, NJ, 07065, USA.
Radim KlapkaMerck & Co., Inc., Rahway, NJ, 07065, USA.
Anna KacprzyckaMerck & Co., Inc., Rahway, NJ, 07065, USA.
Maria Consuelo Luguera FernandezMerck & Co., Inc., Rahway, NJ, 07065, USA.
Ronojit AdyanthayaMerck & Co., Inc., Rahway, NJ, 07065, USA.
Kyle YoungMerck & Co., Inc., Rahway, NJ, 07065, USA.
Jolie WeintraubMerck & Co., Inc., Rahway, NJ, 07065, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveProtocol deviations (PDs) are critical indicators of data quality and operational risk in clinical trials. Systematic under- or over-reporting of PDs at investigator sites can obscure true trial performance and compromise regulatory compliance. The goal of this paper is to present an integrated approach combining statistical outlier detection with generative AI-powered content analysis for detecting and characterizing outlier sites in PD reporting, enabling proactive risk management and targeted site oversight.

resultsIn this study, the simaerep bootstrap algorithm was applied across 578 clinical studies encompassing 39,936 sites. It is shown that the method successfully identifies sites exhibiting statistically significant deviations from expected PD reporting rates, flagging both potential under-reporters and high-rate reporters. In addition, generative AI combined with hierarchical clustering automatically categorized diverse PD narratives into a validated taxonomy of 15 major categories and 47 specific topics through a "human-in-the-loop" refinement process with clinical operations experts. Independent validation of the GenAI topic classification using an "LLM-as-judge" approach achieved 88.7% accuracy (95% CI: 86.5%–90.6%). This integrated capability equips clinical operations teams to identify sites warranting further investigation and determine whether observed deviation patterns are study-systemic, country-specific, or site-specific, ultimately improving data integrity and risk-based audit strategy.

Indexed as

Clinical Trials as TopicAlgorithmsGenerative Artificial IntelligenceHumansClinical trialsData qualityGenerative AIOutlier detectionProtocol deviationsRisk management

Identifiers

PMID41964054
PMCPMC13185178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.